| Primary information |
|---|
| sequence ID | Seq_3080 |
| Peptide sequence | GQDGRPGPPGPPG |
| CancerPDF_ID | CancerPDF_ID8635, CancerPDF_ID10779, |
| PMID | 24416269,21805675 |
| Protein Name | Alpha-1 type I collagen,Collagen alpha-1(I) chain |
| UniprotKB Entry Name | COA1_HUMAN,CO1A1_HUMAN |
| Fluid | Urine,Urine |
| M/Z | 1236.56,1236.5608 |
| Charge | NA,NA |
| Mass (in Da) | NA,NA |
| fdr | NA,NA |
| Profiling Technique | MALDI-TOF,MALDI-TOF |
| Peptide Identification technique | MS/MS,MALDI-TOF-MS |
| Quantification Technique | Affinity Chromatography,NA |
| Labelled/Label Free | Label Free,Label Free |
| FDR | NA,1 |
| CancerPDF_ID | CancerPDF_ID8635, CancerPDF_ID10779, |
| p-Value | less than 0.05,NA |
| Software | MASCOT and Markerview software version 1.2,NA |
| Length | 13,13 |
| Cancer Type | Cervical cancer,Muscle-invasive bladder cancer |
| Database | NA,SwissProt Database |
| Modification | Hydroxylation of Pro,"Oxidation: 6, 9, 12" |
| Number of Patients | 67 patients and 4 healthy,751 bladder cancer and 127 control |
| Regulation | Downregulated in cancer vs normal,Differentially expressed between cancer vs normal samples |
| Validation | NA,Mann-Whitney tests and areas under receiver-operator characteristic |
| Sensitivity | NA,NA |
| Specificity | NA,NA |
| Accuracy | NA,NA |
| Peptide Atlas | NA |
| IEDB | |